Exosome Diagnostics and Leading Academic Cancer Center Demonstrate Superior Liquid Biopsy Performance
November 13, 2017 07:56 ET
|
Exosome Diagnostics
Waltham, MA, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., and MD Anderson Cancer Center had a unique study published in Clinical Cancer Research, a peer reviewed publication of the...
Exosome Diagnostics to Present a Novel Atlas of Exosomal mRNA and Long non-coding RNA Across Biofluids at American Society of Exosomes and Microvesicles Annual Meeting
October 11, 2017 07:30 ET
|
Exosome Diagnostics
Waltham, MA, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. will be presenting the company’s cutting edge long-RNAseq platform at this year’s American Society of Exosomes and...
Exosome Diagnostics and Chesapeake Urology Partner to Evaluate Clinical Value of ExoDx® Prostate(IntelliScore) in First Study Under Novel Evidence Development Collaboration
September 19, 2017 07:31 ET
|
Exosome Diagnostics
Baltimore, MD and Boston, MA, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics (ExoDx) and Chesapeake Urology announced today that they have initiated a new evidence development study to...
Exosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer Panel
August 09, 2017 09:02 ET
|
Exosome Diagnostics
Waltham, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, today announced the launch of the MedOncAlyzer 170, the first liquid biopsy pan-cancer...
Exosome Diagnostics Achieves ISO 13485 Certification
August 03, 2017 07:36 ET
|
Exosome Diagnostics
Waltham, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., a leader in the liquid biopsy market, announced that it has received ISO 13485 certification for both its USA and German...
Corrected: Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA
August 01, 2017 09:01 ET
|
Exosome Diagnostics
Waltham, Mass., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, announced today that it has moved into a new worldwide headquarters and clinical...
Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA
August 01, 2017 07:49 ET
|
Exosome Diagnostics
Waltham, Mass., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, announced today that it has moved into a new worldwide headquarters and clinical...
Exosome Diagnostics Completes $30 Million Series C Financing
July 24, 2017 07:55 ET
|
Exosome Diagnostics
Waltham, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics Inc., a leader in the liquid biopsy market, today announced the close of its $30 million Series C financing, led by insiders,...
Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention
June 22, 2017 11:54 ET
|
Exosome Diagnostics
Boston, MA, June 22, 2017 (GLOBE NEWSWIRE) -- John Boyce, President and CEO of Exosome Diagnostics Inc., a leader in the liquid biopsy space, presented a talk entitled “The True Liquid Biopsy”...
Liquid Biopsy Breakthrough: Exosome Diagnostics Announces Tissue Specific Exosomal Isolation and Signal to Noise Enhancement Technology to be Unveiled at ASCO
June 01, 2017 07:46 ET
|
Exosome Diagnostics
Cambridge, MA, June 01, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. introduces its Exosome Dx Depletion Enrichment (EDDE) to members of ASCO at the upcoming annual meeting. The patented EDDE...